Safety and efficacy of carfilzomib (CFZ) in previously-treated systemic light-chain (AL) amyloidosis
Cohen, A.D., Liedtke, M., Scott, E.C., Kaufman, J.L., Landau, H., Vesole, D.H., Gasparetto, C., Lentzsch, S., Gomes, C.L., Rosenzweig, M., Sanchorawala, V., Smith, D.D., Comenzo, R., Durie, B.Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.199
Date:
September, 2015
File:
PDF, 244 KB
english, 2015